Cell screening
Latest Content
Cambridge spin-out secures £2.4 million for tumour treatments
University of Cambridge spin-out Spirea Limited has secured £2.4 million in funding from British and American investors to increase drug development.
Product Update
Isogenic Panels of Neuronal iPSC Derivatives
AMSBIO has launched a range of induced pluripotent stem cell (iPSC) derived neural stem cells (NSCs) and neural lineage progenitors.
Case Studies
Performing controlled gas liquid chemistries
Sygnature Discovery describes how the FlowSyn reactor allowed them to perform hazardous chemistries in a controlled manner.
Comment
Fighting Ebola first-hand
Armed with clinical diagnostics expertise and vital information on the treatment of exotic pathogens, UWE postgraduate Laura Holding discusses the spread of Ebola, and how her lab in Sierra Leone is …
Features
Editor's comment | The gift of genetics
With Christmas fast approaching, what better gift is there than the £125 personal genetics kit from genetics firm 23andMe?
